Saudi Arabia Diabetes Drugs Market Share

Market Share of Saudi Arabia Diabetes Drugs Industry

The Saudi Arabia Diabetes Drugs Market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones.

Saudi Arabia Diabetes Drugs Market Leaders

1. AstraZeneca

2. Boehringer Ingelheim

3. Merck and Co.

4. Novo Nordisk A/S

5. Sanofi Aventis

*Disclaimer: Major Players sorted in no particular order